This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Apr 1;178(4):587.

doi: 10.1001/jamainternmed.2017.8703.

Assessing Pharmaceutical Research and Development Costs

Joseph A DiMasi¹

Affiliations

PMID: 29610869
DOI: 10.1001/jamainternmed.2017.8703

Comment

Assessing Pharmaceutical Research and Development Costs

Joseph A DiMasi. JAMA Intern Med. 2018.

. 2018 Apr 1;178(4):587.

doi: 10.1001/jamainternmed.2017.8703.

Author

Joseph A DiMasi¹

Affiliation

¹ Tufts Center for the Study of Drug Development, Tufts University, Boston, Massachusetts.

PMID: 29610869
DOI: 10.1001/jamainternmed.2017.8703

No abstract available

PubMed Disclaimer

Comment in

Assessing Pharmaceutical Research and Development Costs-Reply.
Prasad V, Mailankody S. Prasad V, et al. JAMA Intern Med. 2018 Apr 1;178(4):588-589. doi: 10.1001/jamainternmed.2017.8737. JAMA Intern Med. 2018. PMID: 29610885 No abstract available.

Comment on

Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval.
Prasad V, Mailankody S. Prasad V, et al. JAMA Intern Med. 2017 Nov 1;177(11):1569-1575. doi: 10.1001/jamainternmed.2017.3601. JAMA Intern Med. 2017. PMID: 28892524 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations